⌘K

Login Start Free

Home/Filings/4/0001104659-20-063184

4//SEC Filing

Erlander Mark 4

Accession 0001104659-20-063184

CIK 0001213037other

View on SEC.gov Company Profile

Filed

May 17, 8:00 PM ET

Accepted

May 18, 4:17 PM ET

Size

4.6 KB

Accession

0001104659-20-063184

Insider Transaction Report

Form 4

Period: 2020-05-14

Cardiff Oncology, Inc.CRDF

DirectorChief Executive Officer

Transactions

Purchase
Common Stock
2020-05-14$1.43/sh+6,993$10,000→ 13,369 total

Documents

1 file

4
a4.xmlPrimary
4

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1

filerCIK 0001651537

Filing Metadata

Form type: 4
Filed: May 17, 8:00 PM ET
Accepted: May 18, 4:17 PM ET
Size: 4.6 KB

View on SEC.gov